Pritesh Shah, Chief Commercial Officer at NovoCure Ltd (NVCR), sold 2,086 shares at $200.86 ($419K) on 2021-05-04, disclosed to the SEC on 2021-05-05.
Open-market sale of $419k NVCR by Chief Commercial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $200.86 | 1,043 | $209K | 50.0% |
| 2 | $200.86 | 1,043 | $209K | 50.0% |
| Total | $200.86 avg | 2,086 | $419K | 100% |
| Filing → |
| NVCR | SELL | 2023-03-07 | $3.3M | — | Filing → |
| NVCR | SELL | 2023-03-06 | $141K | — | Filing → |
| NVCR | SELL | 2023-03-02 | $294K | — | Filing → |